Autologous CD133(+) cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous CD133(+) cells, covering 2016-09-28 to 2016-09-28. Get the full timeline:
Most recent: Clinical Trial Update: Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty [Phase 1]